Middle Molecule Find

Updates › 30 Oct 2026

What does the 2027 payment rule change, and does it touch the Conditions?

Issued
30 Oct 2026
Verdict
Payment changed; the Conditions didn't
Checked
11 Nov 2026
By
John Cruz, RN
Covers
The final rule's summary of major provisions (sections I.B and I.C), its CFR references and its effective date
Not compared
The wage index values for your area; outlier and add-on amounts beyond those named; the full QIP scoring tables

It changes what Medicare pays starting January 1, 2027, and what QIP will score from payment year 2029.1 It changes payment, not the Conditions: the rule amends 42 CFR Part 413 and leaves Part 494 alone. The base rate rises to $297.52 per treatment, the home training add-on rises to $138.00, and QIP's Hypercalcemia reporting measure gives way to a Hyperphosphatemia clinical measure.1,2

By role

Administrator
CMS projects a 2.7 percent overall increase in Medicare payments for 2027. Your own number depends on your wage index and patient mix.
Billing
New base rate and training add-on from January 1. Post-TDAPA amounts are now set quarterly, so the first quarter's figures are the only ones final today.
Home program manager
The training add-on is $138.00, and training in the first 120 days can now be paid.
QAPI and data lead
Calcium reporting stops counting for QIP from payment year 2029; phosphorus becomes a scored clinical measure. Each payment year scores performance from two years earlier: calendar year 2027 data sets payment year 2029.

What changed

Each row: where it lives, what it now says, when it was actually decided, and how much it binds.
WhereWhat it now saysDecided whenHow much it bindsWhere it says so
PPS base rate
$297.52 per treatment, up from $281.71. It includes $12.85 added as phosphate binders move into the base rate at the end of their TDAPA period.
Effective January 1, 2027
RequiredCMS program rule
Home and self-dialysis training add-on
$138.00 per training treatment, up from $95.60. Training sessions may now be paid during the onset period (the first 120 days of dialysis); the onset adjustment factor drops from 1.327 to 1.311.Applies to: Home (PD and home HD)
Effective January 1, 2027
RequiredCMS program rule
Low-volume payment adjustment
Expanded to facilities furnishing up to 8,000 treatments a year, paid in 6 volume tiers. Budget neutral.
Effective January 1, 2027
RequiredCMS program rule
QIP measures
The Hypercalcemia reporting measure is replaced by a Hyperphosphatemia clinical measure. The NHSN bloodstream infection measure gets new baseline data and risk adjustment. The medication reconciliation and staff COVID-19 vaccination reporting measures are removed.
Beginning payment year 2029
RequiredCMS program rule
AKI dialysis rate
$297.52, the same as the 2027 base rate.
Effective January 1, 2027
RequiredCMS program rule

What didn't change

  • 42 CFR Part 494, the Conditions for Coverage. The rule's only CFR reference is Part 413. It restates that the Conditions apply the same way to AKI patients in a certified facility.1,2
  • The QIP's maximum payment reduction: up to 2 percent for a facility below the minimum total performance score.3

Lines on this site it touches

What this entry can't tell you

  • Your facility's 2027 rate. That takes your wage index and adjustments.
  • How the Hyperphosphatemia measure will be specified in detail. Check the payment year 2029 measure specifications when CMS posts them.

What's next

The proposed rule for 2028, when CMS publishes it.

Sources

  1. CY 2027 ESRD PPS, AKI and ESRD QIP final rule (CMS-1846-F)91 FR 68736 (October 30, 2026), FR Doc. 2026-22194; effective January 1, 2027 · read at the issuer · checked 11 Nov 2026
  2. Federal Register: final rules affecting 42 CFR Part 494federalregister.gov document search, CFR 42 Part 494, type Rule · read at the issuer · checked 11 Nov 2026
  3. 42 CFR 413.177 and 413.17842 CFR 413.177(a); 413.178 · read at the issuer · checked 11 Nov 2026

Entries are fixed once published. A correction is added as a dated line; nothing is rewritten.